Rchr
J-GLOBAL ID：200901041489996525
Update date: Oct. 15, 2024
Inotsume Nobuo
Inotsume Nobuo
Research field (2)：
Clinical pharmacy
, Pharmacology
Research theme for competitive and other funds (5)：
- 2014 - 2017 Relationship between serum EETs concentrations and cardiovascular events in patients taking angiotensin II receptor blockers
- 2010 - 2012 Inhibitory effects of losartan on arachidonic acid metabolism via cytochrome P450(CYP) enzymes
- 2010 - 2012 Establishment of rational usage method of ritodrine for preterm labor therapy
- 1990 - 1992 Development of Highly Efficient System for Optical Resolution
- 1991 - 1991 ベンズアミド系薬物の尿排泄に及ぼす尿細管分泌阻害薬の影響
Papers (84)：
-
石村 淳, 猪爪 信夫, 大田 祥子, 都築 稔. 切迫早産に対する薬物療法の国際比較. 日本臨床薬理学会学術総会抄録集. 2022. 43回. 3-089
-
Yuji Mukai, Tatsunari Yoshida, Takeshi Kondo, Jun Miura, Nobuo Inotsume, Takaki Toda. Development and Validation of a Simple Method for Simultaneously Measuring the Concentrations of BCR-ABL and Bruton Tyrosine Kinase Inhibitors in Dried Blood Spot (DBS): A Pilot Study to Obtain Candidate Conversion Equations for Predicting Plasma Concentration Based on DBS Concentration. Therapeutic drug monitoring. 2022. 44. 6. 762-770
-
佐古 兼一, 猪爪 信夫. 【血中濃度測定の臨床的意義と臨床応用】新規抗てんかん薬のTDM. 臨床精神薬理. 2022. 25. 1. 25-31
-
Yuji Mukai, Azusa Wakamoto, Tae Hatsuyama, Tatsunari Yoshida, Hideki Sato, Akihisa Fujita, Nobuo Inotsume, Takaki Toda. An Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of Afatinib, Alectinib, Ceritinib, Crizotinib, Dacomitinib, Erlotinib, Gefitinib, and Osimertinib in Human Serum. Therapeutic drug monitoring. 2021. 43. 6. 772-779
-
Yuka Kato, Asuna Senda, Yuji Mukai, Miki Yamashita, Yuki Sasaoka, Minayo Hanada, Fuminori Hongo, Mitsugu Hirokami, Anders Rane, Nobuo Inotsume, et al. Correction to: Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center. European journal of clinical pharmacology. 2021. 77. 7. 1077-1077
ｍore...
MISC (45)：
-
佐古 兼一, 猪爪 信夫, 前田 智司, 松田 佳和, 都築 稔. 新規抗てんかん薬の処方率の年次解析とそのTDMの文献的考察. 日本薬学会年会要旨集. 2022. 142年会. 27PO1-84
-
佐古 兼一, 猪爪 信夫. 【血中濃度測定の臨床的意義と臨床応用】新規抗てんかん薬のTDM. 臨床精神薬理. 2022. 25. 1. 25-31
-
向 祐志, 吉田 達成, 三浦 淳, 近藤 健, 猪爪 信夫, 戸田 貴大. BCR-ABLチロシンキナーゼ阻害薬を対象とした乾燥ろ紙血 血漿中薬物濃度換算式の導出. TDM研究. 2021. 38. 2. 205-205
-
向 祐志, 近藤 健, 吉田 達成, 三浦 淳, 猪爪 信夫, 戸田 貴大. BCR-ABLおよびブルトン型チロシンキナーゼ阻害薬の乾燥ろ紙血中薬物濃度一斉分析法の確立とその臨床適用. 臨床薬理. 2020. 51. Suppl. S321-S321
-
向 祐志, 吉田 達成, 猪爪 信夫, 戸田 貴大. 上皮成長因子受容体チロシンキナーゼ阻害薬および未分化リンパ腫キナーゼ阻害薬の血清中濃度一斉分析法の開発. 日本薬学会年会要旨集. 2020. 140年会. 27P-am162
ｍore...
Work history (6)：
Return to Previous Page
